Is Bone Biologics Corporation (BBLG) a Buy, Sell, or Hold?
NASDAQ : BBLG
Bone Biologics Corporation
$0.94 USD
$0.06 (6.87%)
- Volume
- 6.16K
- Average Volume
- 48.41K
- Market Capitalization
- $1.7M
- P/E Ratio
- -0.34
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $4.13
- Year Low
- $0.83
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $16.09
Company Overview
NASDAQ
Jeffrey Frelick
Biotechnology
Healthcare
BBLG
2
US
USD
Liquidity Metrics
0.00
16.09
16.09
14.64
0.00
Sales & Valuation
-$
0.00
0.36
-0.66
-1.43
Profitability
-$2.65
-$3.11M
0.00%
0.00%
-50.45%
-57.40%
P/E Metrics
-0.34
-0.04
-0.04
Analyst Price Target & Rating
2/5
0 Analysts
%
Financial Health Scores
-22.48
3/9
$4.67M
$4.98M
$309.39K
-$2.85M
Key Metrics (TTM)
-$2.94M
0.00
1.38
16.09
-50.45%
-64.27%
-180.98%
-161.35%
0 days
Company Executives
| Name | Title |
|---|---|
| Jeffrey Frelick | Chief Executive Officer & President |
| Deina H. Walsh | Chief Financial Officer |
Poll Results
No votes yet today — be the first to share your view!
About Bone Biologics Corporation (NASDAQ:BBLG) Stock
Bone Biologics Corporation, a medical device enterprise, specializes in fostering bone regeneration for spinal fusion, leveraging its advanced recombinant human protein technology. Its flagship product, NELL-1/DBX, is a unique combination of an osteostimulative recombinant protein designed for precise, targeted control over bone regrowth. The company is currently advancing the NELL-1/DBX Fusion Device, intended for spinal fusion interventions in skeletally mature individuals experiencing single-level degenerative disc disease within the L4-S1 spinal segments. This versatile platform technology also holds the potential to deliver superior outcomes across a wide spectrum of surgical specialties, including spinal, various orthopedic fields, plastic reconstruction, neurosurgery, interventional ... radiology, and sports medicine. Bone Biologics holds a licensing agreement with the UCLA Technology Development Group, which authorizes the development and commercialization of NELL-1 for its spinal fusion applications. The firm was established in 2004 and is based in Burlington, Massachusetts.
Bone Biologics (BBLG) to Announce Earnings on Thursday
2026-08-06 03:11:15
Bone Biologics (NASDAQ: BBLG - Get Free Report) will likely be issuing its results before the market opens on Thursday, August 13th. Analysts expect Bone Biologics to announce earnings of ($0.39) per share for the quarter. Bone Biologics (NASDAQ: BBLG - Get Free Report) last released its earnings results on Thursday, May 14th. The company reported ($0.43)
Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities
2026-07-23 08:00:00
BURLINGTON, Mass, July 23, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation (Nasdaq: BBLG, BBLGW) ("Bone Biologics" or the "Company"), a developer of orthobiologic products for spine fusion markets, today issued a shareholder update summarizing the Company's progress through the first half of 2026, including its recently completed financing, continued advancement of NB1, its rhNELL-1-based bone graft product candidate, and further validation of its manufacturing and product stability profile. “During the first half of 2026, we strengthened several of the fundamental drivers underlying NB1's development and long-term value proposition: clinical execution, product stability, intellectual property protection and capital visibility,” said Bone Biologics CEO Jeff Frelick.
2026-07-07 20:00:00
$3.0 million upfront with up to approximately $6.0 million of potential additional gross proceeds upon the exercise in full of warrants in cash $3.0 million upfront with up to approximately $6.0 million of potential additional gross proceeds upon the exercise in full of warrants in cash
Frequently Asked Questions
-
What is the current Bone Biologics Corporation (BBLG) stock price?
-
Bone Biologics Corporation(NASDAQ:BBLG) stock price is $0.94 in the last trading session. During the trading session, BBLG stock reached the peak price of $4.13 while $0.83 was the lowest point it dropped to. The percentage change in BBLG stock occurred in the recent session was 6.87% while the dollar amount for the price change in BBLG stock was $0.06.
-
BBLG's industry and sector of operation?
-
The NASDAQ listed BBLG is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of BBLG?
-
Jeffrey Frelick | Chief Executive Officer & President
Deina H. Walsh | Chief Financial Officer
|
|
| -
How many employees does BBLG have?
-
Number of BBLG employees currently stands at 2. BBLG operates from 2 Burlington Woods Drive, Burlington, MA 01803, US.
-
Link for BBLG official website?
-
Official Website of BBLG is: https://www.bonebiologics.com
-
How do I contact BBLG?
-
BBLG could be contacted at phone #781 552 4452 and can also be accessed through its website. BBLG operates from 2 Burlington Woods Drive, Burlington, MA 01803, US.
-
How many shares of BBLG are traded daily?
-
The average number of BBLG shares traded daily for last 3 months was 48.41K.
-
What is the market cap of BBLG currently?
-
The market value of BBLG currently stands at $1.7M with its latest stock price at $0.94